Presentations

I have presented at a range of local, national and international conferences, workshops and meetings. If you would like more information about any of these presentations, or copies of the slides or posters, please get in touch.

Selected presentations

  1. Pearce A, Thow AM (2020). Engaging students and tutors in course feedback to improve health policy and health economics teaching and learning at the Masters level. Council of Academic Public Health Institutions Australasia Conference, Newcastle (moved online due to COVID19).
  2. Pearce A, Street D, Karikios D, Viney R (2019). Trading between quality of life and survival when choosing cancer treatments: A discrete choice experiment. Health Services & Policy Research Conference, Auckland.
  3. Pearce A, Street D, Karikios D, McCaffery K, Viney R. (2019). Are we accurately capturing health preferences from people with poor health literacy? Health Services & Policy Research Conference, Auckland.
  4. Manipis K, Haywood P, Hanly P, Viney R, Goodall S, Pearce A (2019). Estimation of the friction period in Australia. Health Services & Policy Research Conference, Auckland.
  5. Yim J, Arora S, Shaw J, Street D, Pearce A, Viney R (2019). Preferences for anxiety and depression screening in cancer care – A discrete choice experiment. Health Services & Policy Research Conference, Auckland.
  6. Pearce A, Street D, Karikios D, Viney R (2019). Patient preferences for approaches to cancer treatment – trading between quality of life and survival. International Academy of Health Preferences Research, Auckland.
  7. de Camargo Cancela M, Pearce A, Barchuk A, Borges L, Hanly P, Martins LF, Sharp L, Soerjomataram I (2019). Sustainable development goals and cancer in Brazil: Regional disparities in cervical and breast cancer mortality. Workshop on the Economics of Health, Inequality and Behaviour, Sydney.
  8. Christie L, Acworth N, McCluskey A, Lovarini M, Rendell R, Pearce A (2019). An economic evaluation of constrint-induced movement therapy (CIMT) implementation in a public health setting: The ACTIveARM Project. Australian Occupational Therapy Conference, Sydney. 
  9. Carrello J, Pearce A, Girgis A, Butow P, Bamboje A, O’Dea B, Delaney G, Kiely B, Smith K, Smith A (2019). The cost-effectiveness of stepped care for fear of cancer recurrence. Cancer Research Symposium, University of Sydney.
  10. Pearce A, Street D, Karikios D, McCaffery K, Viney R. (2019). Do people with poor health literacy report greater difficulty with discrete choice experiments? Australian Health Economics Society Conference, Melbourne. 
  11. Pearce A (2019). Work after cancer – the value and costs. University of Calgary O’Brien Institute of Public Health Seminar. [Invited speaker – Recording]
  12. Pearce A (2019). Social media as a strategy for career development. University of Calgary Health Economics Trainee Rounds. [Invited speaker – Slides]
  13. Pearce A (2019). Do people understand discrete choice experiment surveys (and how can we tell?). C2E2 Rounds, Vancouver. [Invited speaker – Slides]
  14. Pearce A (2018). Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China and South Africa (BRICS). HSRAANZ Webinar. [Recording]
  15. Pearce A, Mulhern B, Viney R, Watson V (2018). How common and useful are debriefing questions in health DCEs? International Academy of Health Preferences Research, Montreal
  16. Pearce A (2018). Rational decision making in discrete choice experiments. Monash Centre for Health Economics Seminar Series. [Invited speaker].
  17. Manipis K, Pearce A, Hanly P,  Haywood P, Goodall S. (2018). Estimating the friction period for Australia. Australian Health Economics Society, Hobart. 
  18. Pearce A. (2017). The cost of lost productivity due to cancer. Cancer Institute NSW Forum, Sydney. [Invited speaker]
  19. Pearce A, Shaw J, Lopez A, Price M (2017). Comorbid anxiety and resource use. PsychoOncology Cooperative Trials Group Scientific Meeting, Sydney. [Slides]
  20. Tomalin B, Pearce A, Kaambwa B, Horevoorts N, Duijts S, Mols F, van de Poll-Franse L, Koczwara B. (2017). Is there a relationship between financial toxicity and employment status in cancer survivors? A secondary analysis of the PROFILES registry. Clinical Oncology Society of Australia Conference, Sydney. 
  21. Pearce A. (2017). Social media as a strategy for career development. Australian Health Economics Doctoral Workshop, Sydney. Slides. [Invited speaker]
  22. Pearce A. (2017). Estimating the costs of cancer. Adelaide Health Economics Workshop, Adelaide. Slides. [Invited presentation]
  23. Pearce A. (2017). Work after cancer – the value and the costs. Cancer Insights Public Lecture, Flinders Medical Centre, Adelaide. Slides. [Invited presentation]
  24. Pearce A. (2017). Getting your career out there – overseas and online. Early Career Researcher Seminar, Adelaide. Slides. [Invited presentation]
  25. Pearce A. (2016). Advances in oncology: Can we afford the future? Sydney Catalyst Education Dinner Debate Series, Sydney. [Invited presentation]
  26. Pearce A, Sharp L, Gallagher P, Timmons A, Watson V. (2016). Cancer survivors find it difficult to think hypothetically about their future care in a DCE: A think aloud study. Australian Health Economics Society Conference, Perth. Slides.
  27. Pearce A. (2016). Moving cancer follow-up into primary care: Exploring the tension between outcomes, costs and patient preferences. Screening and Test Evaluation Program (STEP) Seminar, Sydney. Slides & Audio. [Invited presentation]
  28. Pearce A, Sharp L, Gallagher P, Timmons A, Watson V. (2016). Pre-testing with cognitive interviewing highlights unanticipated decision making in a DCE. International Academy for Health Preferences Research, Singapore. Slides.
  29. Pearce A, Hanly P, Sharp L, Soerjomataram I. (2015). The burden of cancer in emerging economies: Productivity loss as an alternative perspective. International Society of  Pharmacoeconomics and Outcomes Research, Milan. Slides.
  30. Pearce A, Hanly P, Sharp L, Gupta P, Soerjomataram I. (2015). Cancer-related productivity losses in emerging economies. International Association of Cancer Registries Conference, Mumbai. Slides.
  31. Pearce A & Ryan F (joint first authors), Timmons A, Thomas A, Drummond F, Sharp L* and the ICE Survivorship Investigators (2015). Comparing the costs of three prostate cancer follow-up strategies: A cost minimisation analysis. MASCC/ISOO Annual Meeting on Supportive Care in Cancer, Copenhagen. Slides.
  32. Pearce A, Haas M, Viney R, Pearson SA, Haywood P*, Ward R and the EMCAP Investigators (2014). Rates of chemotherapy adverse events in clinical practice: results from a prospective cohort study. World Cancer Congress 2014, Melbourne. Slides
  33. Pearce A*, Bradley C, Hanly P, O’Neill C, Sharp L (2014). Projecting productivity losses due to premature mortality from cancer 2010 – 2030. Irish Society for New Economists, Galway. Slides.
  34. Pearce A*, Timmons A, Hanly P, O’Neill C, Sharp L (2014). Comparing the Human Capital and Friction Cost approaches to estimating productivity costs. International Health Economics Association Congress, Dublin. Slides.
  35. Pearce A*, Haas M, Viney R (2013). Chemotherapy adverse events in a large Australian administrative dataset. Irish Society of New Economists Conference, Maynooth. Slides.
  36. Pearce A*, Haas M, Viney R (2013). The incidence and costs of chemotherapy side effects. 10th Summer Workshop in Health Economics, Sydney. Slides.
  37. Pearce A*, Haas M, Viney R (2012).  Examining chemotherapy side effects in a large administrative dataset.  Australian Health Economics Society Conference, Darwin. Slides.
  38. Pearce A*, Haas M, Haywood P, Van Gool K, Gallego G, Pearson S, Faedo M, Ward R (2009). Chemotherapy adverse events and cost.  Health Services and Policy Research Conference, Brisbane. Slides.
  39. Pearce A, Milch V, Wade R*, Anderson K, Care O, Nelson A, Zorbas H (2009). Recommendations for creating a strategic approach to sustainable guideline development. Guidelines International Network Annual Conference, Portugal.
  40. Care O, Pearce A, Wade R*, Anderson K, Milch V, Nelson A, Zorbas H (2009).  Australia’s approach to consumer involvement in the development of breast and ovarian cancer guidelines. Guidelines International Network Annual Conference, Portugal.
  41. O’Brien J*, Wilcoxon H, Pearce A, Luxford K, Nelson A, Zorbas H, on behalf of the NBOCC’s Axilla Working Group (2009). Staging and managing the axilla in early breast cancer – Guidelines for best practice. Royal Australasian College of Surgeons Annual Meeting, Brisbane
  42. Giles C*, Buckingham J, Delany G, Pearce A, Wilcoxon H, Hastings P, Zorbas H, on behalf of the NBOCC’s Post-Surgical Care Working Group (2009).  Post-surgical care in breast cancer – Process mapping current models in Australia. Royal Australasian College of Surgeons Annual General Meeting, Brisbane
  43. Giles C, White K, Pearce A, Wilcoxon H*, Hastings P, Zorbas H, on behalf of the NBOCC’S Post-Surgical Care Working Group (2009). Post-surgical care in breast cancer – The nursing perspective. Cancer Nurses Society of Australia Winter Congress, Adelaide
  44. Pearce A*, Care O, Wilcoxon H, Vagg R, Anderson K, Luxford K, Zorbas H (2008). A strategic approach to clinical practice guidelines – an Australian oncology perspective. Guidelines International Network Annual Conference, Helsinki
  45. Nehill C*, Turner J, Luxford K, Care O, Pearce A, Zorbas H (2008). A national approach to the implementation of psychosocial care guidelines for adults with cancer. Guidelines International Network Annual Conference, Helsinki
  46. Nehill C*, Turner J, Luxford K, Care O, Zorbas H, Pearce A (2008). A national approach to implementation of psychosocial care for adults with cancer. International union against cancer, Geneva
  47. Pearce A* (2008). Clinical Practice Guideline Implementation. NICS Fellowship Workshop – Getting to Grips with Guidelines, Sydney.
  48. Giles C*, Delaney G, Buckingham J, Pearce A, Care O, Zorbas H, on behalf of NBOCC’S Sentinel Node Biopsy Working Group (2008). Post-surgical care for women with breast cancer. Royal Australasian College of Surgeons Annual General Meeting, Hong Kong.
  49. Wetzig N, Wilcoxon H, Pearce A, Vagg R, Anderson K, Luxford K, Zorbas H, on behalf of NBOCC’S Sentinel Node Biopsy Working Group (2008). Clinical practice guidelines for sentinel node biopsy in early (operable) breast cancer. Royal Australasian College of Surgeons Annual General Meeting, Hong Kong.
  50. Pearce A*, Luxford K, Care O, Webb J, Giles C (2008). Is post-surgical care for women with breast cancer changing due to decreasing length of stay? Breast Cancer Nurses Conference, Perth.
  51. Wetzig N*, Wilcoxon H, Pearce A, Vagg R, Anderson K, Luxford K, Zorbas H, on behalf of NBOCC’S Sentinel Node Biopsy Working Group (2008).  Clinical practice guidelines for sentinel node biopsy in early (operable) breast cancer. International Sentinel Node Symposium, Sydney.
  52. Pearce A (2007). Performance indicators for psychosocial and multidisciplinary care. CanNet Workshop, Adelaide.
  53. Pearce A & Aiken C* (2006). From Idea to Initiation: Translating a scientific idea into an operational protocol in oncology clinical trials. Australasian Gastro-Intestinal Trials Group Scientific Meeting, Adelaide.
  54. Pearce A (2006). Audit and Monitoring Workshop. Introduction to Trial Management Course, Sydney.
  55. Pearce  A* (2006). The CTC Oncology Program. Australasian Lung Cancer Trials Group Meeting, Australian Lung Cancer Conference, Cairns.
  56. Pearce  A (2005). CO.17 Data Managers’ Workshop [Chair]. NHMRC Clinical Trials Centre, Sydney.
  57. Pearce A* (2002). Client satisfaction with the services provided by the SWS Carer Respite Centre. SWSAHS Allied Health Outcomes Conference, Sydney.
  58. Pearce A* (2002). A journey to Evidence-based practice [Keynote Address]. Bankstown Health Service 2002 Outcomes Conference, Sydney.
  59. Pearce A* (2001). Evidence-based practice – Asking and searching for the right questions (Lecture). The New South Wales College of Nursing, Sydney.
  60. Goodger S* & Pearce A* (2000). An Evidence-Based Review of Splinting and Casting in Neurology. National Occupational Therapy Conference, Brisbane.

Posters

  1. De Camargo Cancela M, Borges de Souza L, Felipe Martins L, Souza D, Barchuk A, Schilithz A, Hanly P, Sharp L, Pearce A, Soerjomataram I. (2020). The economic impact of cancer-related premature mortality in Brazil: a human capital approach analysis. American Society of Clinical Oncology (Virtual) Meeting 2020
  2. Christie L, Acworth N, Lovarini M, McCluskey A, Rendell R, Pearce A. (2019). An economic evaluation of constraint-induce movement therapy implementation: The ACTIveARM Project. Australiasian Society for the Study of Brain Impairment, Wellington.
  3. Pearce A, Manipis K, Haywood P, Hanly P, Goodall S. (2018). Local inputs for a societal perspective: Estimating the friction period in Australia. [Poster]. International Society for Pharmacoeconomics and Outcomes Research, Tokyo.
  4. Manipis K, Mulhern B, Pearce A, Haywood P, Viney R, Goodall S. (2018). Estimating the willingness to pay to avoid the impacts of foodborne illness: A discrete choice experiment. [Poster]. International Society for Pharmacoeconomics and Outcomes Research, Tokyo.
  5. Pearce A, Shaw J, Lopez A, Price M. (2017). Does comorbid anxiety increase health resource use or costs among cancer patients? A review of the evidence. [Poster]. Clinical Oncology Society of Australia Conference, Sydney. 
  6. Norman R, Mulhern B, Bansback N, Pearce A, Viney R. (2016). The impact of duration on EQ-5D-5L value sets derived from a discrete choice experiment. [Poster]. International Society of  Pharmacoeconomics and Outcomes Research, Singapore.
  7. Pearce AM, Watson V, Gallagher P, Timmons A, Sharp L. (2016). Pre-testing with cognitive interviews highlights unanticipated decision making in a DCE. [Poster]. Health Economics Study Group Winter Meeting 2016, Manchester.
  8. Hanly P, Pearce A, Sharp L. (2015). Cancer and premature mortality in Ireland: An employer’s perspective following the friction cost approach. [Poster]. ISPOR 18th Annual European Congress, Milan.
  9. Pearce A, Bradley C, Hanly P, Thomas AA, O’Neill C, Molcho M, Sharp L. (2015). Productivity losses for cancer-related mortality in Ireland: Projecting from 2011 to 2030. [Poster]. National Cancer Research Institute Cancer Conference, Liverpool.
  10. Pearce A, Timmons A, Hanly P, Wlash P, O’Neill C, Sharp L (2014). Using registry data to estimate productivity losses due to premature mortality and reduced workforce participation following head and neck cancer [Poster]. NCIN Cancer Outcomes Conference, Birmingham.
  11. Pearce A, Timmons A, Hanly P, O’Neill C, Sharp L in association with ICE Cancer Survivorship Award Investigators and SUN Study Investigators (2013). Workforce participation and productivity losses after head and neck cancer [Poster]. International Society of Pharmacoeconomics and Outcomes Research, Dublin
  12. Pearce A, Haas M, Viney R (2013). Can administrative data predict chemotherapy adverse events? [Poster]. International Society of Pharmacoeconomics and Outcomes Research, Dublin
  13. Pearce A, Haas M, Viney R (2013). Australian standard costs and consequences of four chemotherapy adverse events [Poster].  International Society of Pharmacoeconomics and Outcomes Research, Dublin
  14. Pearce A, Van Gool K, Haywood P, Haas M (2011).  Delaying access to new medicines [Poster].  Health Services Research and Policy Conference, Adelaide. 
  15. Pearce A, Haas M, Van Gool K, on behalf of EMCaP Investigators (2010) The cost of chemotherapy side effects: Recommendations for local modelling and economic evaluation [Poster].  International Society of Pharmacoeconomics and Outcomes Research, Thailand.
  16. Pearce A, Haas M, Van Gool K, Haywood P, on behalf of EMCaP Investigators (2010). Can we calculate the costs of haematological side effects of systemic therapy? [Poster]  Sydney Cancer Conference, Sydney.
  17. Pearce A, Wade R, Anderson K, Milch V, Care O, Nelson A, Zorbas H (2009). Reviewing the guideline development process – a quest of innovation and sustainability [Poster].  Guidelines International Network Annual Conference, Portugal.
  18. Pearce A & Smead J (2003). Occupational therapy driver assessments ensure safe driving for up to 18 months following stroke [Poster]. National Occupational Therapy Conference, Melbourne.